Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/04/051931
CTRI/2023/04/051931
Completed
Phase 4

A Open label Clinical Study to Evaluate the Efficacy and Safety of URAL Tablet in Urolithiasis

Vasu Research Centre0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Vasu Research Centre
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Vasu Research Centre

Eligibility Criteria

Inclusion Criteria

  • •1\.Subject with Urolithiasis as diagnosed by clinical with calculi measuring \< 10mm. Hematologic and Biochemical parameters within normal limits (Study specific parameters: calcium, uric acid cannot be more than 2 times upper limit of normal value).
  • •2\. Aged between \=18 to \= 50 years.
  • •3\. Subjects willing to sign informed consent and follow the study
  • •procedure and instructions.
  • •4\. Subjects who are diagnosed of diabetes mellitus, whose blood
  • •glucose level is under good control with consumption of
  • •Anti\-hyperglycemic medications and the Random Blood Sugar
  • •(RBS) reading is \= 200mg/dl during the screening period, can
  • •be included in the study.

Exclusion Criteria

  • •1\. Subjects with severe obstructive uropathy, those with serious
  • •systemic medical disorder\- uncontrolled hypertension and
  • •diabetes mellitus, other metabolic disorders, endocrinal
  • •disorders and cardiac illness.
  • •2\. The subjects not to have used any drugs, for at least 1 week
  • •prior to the study for concurrent illness with diabetes and
  • •Hypertension.
  • •3\. Subjects with a strong history of food or drug allergy of any

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
An Clinical Study of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome)
CTRI/2017/12/011004The Himalaya Drug Company
Completed
Not Applicable
Study to Determine the Effect of Trucrose in Patients with Type II Diabetes MellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2020/07/026346Trulit Herbals
Recruiting
Not Applicable
Abnormal Uterine Bleeding ManagementHealth Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
CTRI/2021/12/038921Magnet Labs under Mankind Pharma
Not yet recruiting
Phase 3
A CLINICAL STUDY TO KNOW THE EFFECT OF AN AYURVEDIC FORMULATION (GUDA-HARITAKI WITH GUDUCHI KASHAYAM) FOR THE TREATMENT OF VATA RAKTA, GOUTY ARTHRITIS.Health Condition 1: M100- Idiopathic gout
CTRI/2022/09/045834Jammu Institute of Ayurveda and Research Jammu
Not yet recruiting
Phase 2
A Study to Evaluate The Effect of Draksha (Vitis Vinifera Lin) Panak in Dyslipidaemia.Health Condition 1: E784- Other hyperlipidemia
CTRI/2021/07/034572Sane Guruji Arogya Kendra